Geode Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.51M Buy
3,499,332
+81,243
+2% +$58.3K ﹤0.01% 3066
2025
Q1
$5.03M Buy
3,418,089
+111,519
+3% +$164K ﹤0.01% 2651
2024
Q4
$14.7M Buy
3,306,570
+13,028
+0.4% +$57.7K ﹤0.01% 2131
2024
Q3
$13.6M Sell
3,293,542
-78,780
-2% -$325K ﹤0.01% 2193
2024
Q2
$22M Buy
3,372,322
+225,164
+7% +$1.47M ﹤0.01% 1883
2024
Q1
$27.4M Buy
3,147,158
+66,695
+2% +$581K ﹤0.01% 1736
2023
Q4
$35.2M Buy
3,080,463
+156,340
+5% +$1.79M ﹤0.01% 1561
2023
Q3
$28.2M Buy
2,924,123
+131,838
+5% +$1.27M ﹤0.01% 1599
2023
Q2
$29.7M Buy
2,792,285
+158,481
+6% +$1.69M ﹤0.01% 1594
2023
Q1
$27.7M Buy
2,633,804
+118,514
+5% +$1.25M ﹤0.01% 1585
2022
Q4
$31.2M Buy
2,515,290
+49,663
+2% +$615K ﹤0.01% 1476
2022
Q3
$25.5M Sell
2,465,627
-149,412
-6% -$1.55M ﹤0.01% 1558
2022
Q2
$30.2M Sell
2,615,039
-143,697
-5% -$1.66M ﹤0.01% 1474
2022
Q1
$34.7M Sell
2,758,736
-4,832
-0.2% -$60.8K ﹤0.01% 1511
2021
Q4
$32.2M Sell
2,763,568
-47,836
-2% -$558K ﹤0.01% 1637
2021
Q3
$36.7M Buy
2,811,404
+53,995
+2% +$705K ﹤0.01% 1529
2021
Q2
$35.5M Sell
2,757,409
-18,934
-0.7% -$244K ﹤0.01% 1589
2021
Q1
$31M Buy
2,776,343
+302,099
+12% +$3.38M ﹤0.01% 1580
2020
Q4
$28.2M Buy
2,474,244
+116,777
+5% +$1.33M ﹤0.01% 1500
2020
Q3
$21.2M Sell
2,357,467
-59,610
-2% -$536K ﹤0.01% 1502
2020
Q2
$24.9M Buy
2,417,077
+124,431
+5% +$1.28M 0.01% 1339
2020
Q1
$23.1M Buy
2,292,646
+98,558
+4% +$994K 0.01% 1207
2019
Q4
$29.2M Buy
2,194,088
+33,084
+2% +$440K 0.01% 1303
2019
Q3
$18.6M Buy
2,161,004
+36,904
+2% +$317K ﹤0.01% 1539
2019
Q2
$23.2M Sell
2,124,100
-194,623
-8% -$2.13M 0.01% 1386
2019
Q1
$26.3M Buy
2,318,723
+338,171
+17% +$3.83M 0.01% 1238
2018
Q4
$17.2M Buy
1,980,552
+112,777
+6% +$978K 0.01% 1389
2018
Q3
$28.9M Buy
1,867,775
+167,767
+10% +$2.59M 0.01% 1151
2018
Q2
$27.2M Buy
1,700,008
+168,442
+11% +$2.7M 0.01% 1127
2018
Q1
$19.8M Buy
1,531,566
+51,118
+3% +$661K 0.01% 1269
2017
Q4
$18.6M Buy
1,480,448
+36,896
+3% +$463K 0.01% 1311
2017
Q3
$19.1M Buy
1,443,552
+16,769
+1% +$221K 0.01% 1278
2017
Q2
$22.6M Buy
1,426,783
+54,632
+4% +$864K 0.01% 1088
2017
Q1
$19.6M Buy
1,372,151
+127,773
+10% +$1.83M 0.01% 1162
2016
Q4
$15.9M Buy
1,244,378
+64,865
+5% +$831K 0.01% 1260
2016
Q3
$15.7M Buy
1,179,513
+40,398
+4% +$537K 0.01% 1176
2016
Q2
$12.5M Buy
1,139,115
+25,437
+2% +$279K 0.01% 1268
2016
Q1
$10.2K Buy
1,113,678
+69,425
+7% +$636 0.01% 1383
2015
Q4
$10.1M Buy
1,044,253
+54,640
+6% +$530K 0.01% 1378
2015
Q3
$8.64M Buy
989,613
+69,929
+8% +$610K 0.01% 1441
2015
Q2
$9.29M Buy
919,684
+18,639
+2% +$188K 0.01% 1461
2015
Q1
$12.1M Buy
901,045
+46,277
+5% +$620K 0.01% 1243
2014
Q4
$11M Buy
854,768
+20,951
+3% +$269K 0.01% 1253
2014
Q3
$9.05M Buy
833,817
+8,199
+1% +$89K 0.01% 1348
2014
Q2
$10.6M Buy
825,618
+33,890
+4% +$435K 0.01% 1261
2014
Q1
$8.17M Buy
791,728
+178,179
+29% +$1.84M 0.01% 1399
2013
Q4
$5.97M Buy
613,549
+55,568
+10% +$540K ﹤0.01% 1567
2013
Q3
$5.54M Buy
557,981
+67,993
+14% +$675K ﹤0.01% 1487
2013
Q2
$4.08M Buy
+489,988
New +$4.08M ﹤0.01% 1560